# ---------------------------------------------------------------
# Boni Lab Malaria Simulation Configuration
# ---------------------------------------------------------------
# This configuration file runs the malaria simulation from year 2000 to year 2030.
# The drug is deployed in year 2010.

# ---------------------------------------------------------------
# 1. Model Settings
# ---------------------------------------------------------------
model_settings:
  # The number of days between each output to the standard output (stdout).
  # This variable defines the frequency at which notifications or logs
  # are sent to stdout, measured in days.
  days_between_stdout_output: 30

  # Initial seed number for random number generator; set to -1 to use a random seed
  initial_seed_number: 0

  # Record the genomic data (set to true for a real run)
  record_genome_db: true

  cell_level_reporting: false

# ---------------------------------------------------------------
# 2. Simulation Timeframe
# ---------------------------------------------------------------
simulation_timeframe:
  # Simulation starting date (calibration year minus 11 years of burn-in)
  starting_date: 2000/1/1

  # Start of comparison period (mutations start in 2010)
  start_of_comparison_period: 2000/1/1

  # Simulation ending date
  ending_date: 2010/1/1

  # Day to start collecting data
  start_collect_data_day: 0

# ---------------------------------------------------------------
# 3. Transmission Settings
# ---------------------------------------------------------------
transmission_settings:
  # Transmission parameter based on data; adjusts the odds that an individual
  # will be infected when challenged by sporozoites
  # NOTE: this from Robert's sporozoites challenged, Kien to review this
  transmission_parameter: 0.55 #from v4, disabled if it is set to 0

  # Probability that an infectious bite on a human causes a blood-stage malaria infection
  p_infection_from_an_infectious_bite: 0.1

# ---------------------------------------------------------------
# 4. Population Demographic
# ---------------------------------------------------------------
population_demographic:
  # Number of age classes used for reporting age-specific mortality calculations
  number_of_age_classes: 15

  # Age structure used for reporting (in years)
  age_structure: [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 15, 20, 60, 100]

  # Initial age structure used when initializing the model at T=0
  initial_age_structure: [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 25, 35, 45, 55, 65, 100]

  # Crude birth rate (to be updated with specific country data)
  birth_rate: 0.0288

  # Malaria-adjusted all-cause death rate by age class (to be updated with specific country data)
  death_rate_by_age_class: [0.02641, 0.00202, 0.00202, 0.00202, 0.00198, 0.00247, 0.00247, 0.00247, 0.00247, 0.00247, 0.00247, 0.00247, 0.00455, 0.00455, 0.05348]

  # Probability of death for patients who are not treated or experience a treatment failure
  # When receiving treatment, this rate drops by a factor of 10 in the code
  mortality_when_treatment_fail_by_age_class: [0.040, 0.020, 0.020, 0.020, 0.020, 0.004, 0.004, 0.004, 0.004, 0.004, 0.004, 0.001, 0.001, 0.001, 0.001]
  # Scaling factor for the population in the model (based on data)
  artificial_rescaling_of_population_size: 1

# ---------------------------------------------------------------
# 5. Raster and Geographic Settings
# ---------------------------------------------------------------
spatial_settings:
  mode: "grid_based" # or "location_based"
  # mode: "location_based" # or "location_based"
  grid_based:
    # Approximate national age distribution (to be updated with specific country data)
    age_distribution_by_location:
      - [0.0378, 0.0378, 0.0378, 0.0378, 0.0282, 0.0282, 0.0282, 0.0282, 0.0282, 0.029, 0.029, 0.029, 0.029, 0.029, 0.169, 0.134, 0.106, 0.066, 0.053, 0.035, 0.0]

    # Adjusted population raster to account for burn-in up to 2009 start
    #    population_raster: "../../sample_inputs/kag_init_pop.asc"
    population_raster: "../../sample_inputs/dev_init_pop.asc"

    # Raster files defining the country districts
    #    district_raster: "../../sample_inputs/kag_district.asc"
    #    district_raster: "../../sample_inputs/dev_district.asc"

    administrative_boundaries:
      - name: "district" # First admin level
        #       raster: "../../sample_inputs/kag_district.asc"
        raster: "../../sample_inputs/dev_district.asc"

    # Raster files defining treatment probabilities (comment these out for beta calibration)
    #    p_treatment_under_5_raster: "../../sample_inputs/kag_treatment.asc"
    #    p_treatment_over_5_raster: "../../sample_inputs/kag_treatment.asc"
    p_treatment_under_5_raster: "../../sample_inputs/dev_treatment.asc"
    p_treatment_over_5_raster: "../../sample_inputs/dev_treatment.asc"

    # Raster file containing the calibrated beta value
    #    beta_raster: "../../sample_inputs/kag_beta_r1.asc"
    beta_raster: "../../sample_inputs/dev_beta.asc"

    # Raster file containing the seasonal values,
    # use this only when using raster in seasonal equation
    ecoclimatic_raster: "../../sample_inputs/dev_ecozone.asc"

    #Travel (for Burkina Faso)
    travel_raster: "../../sample_inputs/dev_travel.asc"

    # Cell size used by raster, in square kilometers
    cell_size: 5

  location_based:
    # Approximate national age distribution (to be updated with specific country data)
    age_distribution_by_location:
      - [0.0378, 0.0378, 0.0378, 0.0378, 0.0282, 0.0282, 0.0282, 0.0282, 0.0282, 0.029, 0.029, 0.029, 0.029, 0.029, 0.169, 0.134, 0.106, 0.066, 0.053, 0.035, 0.0]

    #id, latitude, longitude
    location_info:
      - [0, 0, 0]

    # probability that a symptomatic and infected individual seeks and receives antimalarial treatment
    #if the number of values less than number of locations, the first value will be applied for all locations
    # this is the initial value, the modification values can be change by setting in events node
    p_treatment_under_5_by_location: [0.600000]
    p_treatment_over_5_by_location: [0.500000]

    #transmission intensity
    #if the number of values less than number of locations, the first value will be applied for all locations
    beta_by_location: [0.05]

    #if the number of values less than number of locations, the first value will be applied for all locations
    population_size_by_location: [10]

# ---------------------------------------------------------------
# 6. Seasonality Settings
# ---------------------------------------------------------------
seasonality_settings:
  # Seasonality of malaria (to be updated with specific country data)
  enable: true
  mode: "pattern"
  pattern:
    admin_level: "district"
    filename: "../../sample_inputs/dev_seasonality_pattern.csv"
    period: 365
  rainfall:
    filename: "../../sample_inputs/dev_seasonality.csv"
    period: 365
  equation:
    # If raster is enabled, make sure to include
    # ecoclimatic_raster in spatial_settings
    raster: true
    base: [0.4]
    a: [0.6]
    b: [2.5]
    phi: [146]

# ---------------------------------------------------------------
# 7. Movement and Spatial Model
# ---------------------------------------------------------------
movement_settings:
  # Country-specific movement model and calibration
  spatial_model:
    name: "BurkinaFaso"
    Barabasi:
      r_g_0: 5.8
      beta_r: 1.65
      kappa: 350
    Wesolowski:
      kappa: 0.01093251
      alpha: 0.22268982
      beta: 0.14319618
      gamma: 0.83741484
    WesolowskiSurface:
      kappa: 0.01093251
      alpha: 0.22268982
      beta: 0.14319618
      gamma: 0.83741484
    Marshall:
      alpha: 1.27
      log_rho: 0.54
      tau: 1.342
    BurkinaFaso:
      alpha: 1.27
      log_rho: 0.25
      tau: 1.342
      capital: 14
      penalty: 12

  # Settings that determine how long an individual stays in a given location
  circulation_info:
    max_relative_moving_value: 35
    number_of_moving_levels: 100
    moving_level_distribution:
      distribution: Gamma
      Exponential:
        scale: 0.17
      Gamma:
        mean: 5
        sd: 10

    # Percentage of the population selected for movement outside of their cell each timestep
    circulation_percent: 0.00336
    length_of_stay:
      mean: 5
      sd: 10

    # From https://github.com/bonilab/Temple-Malaria-Simulation/issues/7
    relative_probability_that_child_travels_compared_to_adult: 1.4
    relative_probability_for_clinical_to_travel: 1.4

# ---------------------------------------------------------------
# 8. Parasite Parameters
# ---------------------------------------------------------------
parasite_parameters:
  parasite_density_levels:
    # Standard values used in other models
    log_parasite_density_cured: -4.699 # Corresponds to 100 total parasites (0.00002 per μl)
    log_parasite_density_from_liver: -2.000 # Corresponds to 50,000 total parasites (0.01 per μl)
    log_parasite_density_asymptomatic: 3 # Corresponds to 1,000 parasites per μl of blood
    log_parasite_density_clinical: 4.301 # Corresponds to 20,000 parasites per μl of blood
    log_parasite_density_clinical_from: 3.301 # Corresponds to 2,000 parasites per μl of blood
    log_parasite_density_clinical_to: 5.301 # Corresponds to 200,000 parasites per μl of blood
    log_parasite_density_detectable: 1.000 # Corresponds to 10 parasites per μl of blood
    log_parasite_density_detectable_pfpr: 1.699 # Corresponds to 100 parasites per μl of blood›
    log_parasite_density_pyrogenic: 3.398 # Corresponds to 2,500 parasites per μl of blood

  recombination_parameters:
    # Within-chromosome recombination rate
    within_chromosome_recombination_rate: 0.1

    # Free recombination among the drug resistance loci
    using_free_recombination: true

# ---------------------------------------------------------------
# 9. Immune System Parameters
# ---------------------------------------------------------------
immune_system_parameters:
  # Parameters governing the immune response
  b1: 0.00125 # Rate at which antimalarial immune function increases when a host is parasitemic
  b2: 0.0025 # Rate at which antimalarial immune function decreases when a host is parasitemic
  duration_for_naive: 300 # Duration of infection for naive hosts
  duration_for_fully_immune: 60 # Duration of infection for fully immune hosts
  mean_initial_condition: 0.1 # Initial immune function mean at time zero
  sd_initial_condition: 0.1 # Initial immune function standard deviation at time zero
  immune_inflation_rate: 0.01 # Age-dependent faster acquisition of immunity from age 1 to age 10 (per year)
  min_clinical_probability: 0.05 # Minimum probability of experiencing symptoms from a new infection
  max_clinical_probability: 0.99 # Maximum probability of experiencing symptoms from a new infection
  immune_effect_on_progression_to_clinical: 5.4 # Slope of the sigmoidal probability vs. immunity function
  age_mature_immunity: 10 # Age at which immune function is mature
  factor_effect_age_mature_immunity: 0.3 # Adjusts the inflection point in the curve
  midpoint: 0.4 # Midpoint for the immunity curve

# ---------------------------------------------------------------
# 10. Mutation and Genotype Parameters
# ---------------------------------------------------------------
genotype_parameters:
  # Mutation mask indicating positions of genetic mutations
  mutation_mask: "||||111||1000000,0||||||0000000000110|1"

  # Daily probability that a parasite will mutate at a given locus when drug concentration is not zero
  mutation_probability_per_locus: 0.001

  pf_genotype_info:
    - chromosome: 5
      genes:
        - name: "Pfmdr1"
          max_copies: 2
          # copy number variation cost of resistances
          cnv_daily_crs: [0, 0.0005]
          cnv_multiplicative_effect_on_EC50:
            - drug_id: 4
              factors: [1, 2.44444444]
            - drug_id: 1
              factors: [1, 1.3]
          multiplicative_effect_on_EC50_for_2_or_more_mutations:
            - drug_id: 1
              factor: 1.05
          aa_positions:
            - position: 86
              amino_acids: ["N", "Y"]
              daily_crs: [0, 0.0005]
              multiplicative_effect_on_EC50:
                - drug_id: 6
                  factors: [1, 1.25]
                - drug_id: 1
                  factors: [1.25, 1]
                - drug_id: 2
                  factors: [1, 1.42]
            - position: 184
              amino_acids: ["Y", "F"]
              daily_crs: [0, 0.0005]
              multiplicative_effect_on_EC50:
                - drug_id: 1
                  factors: [1, 1.25] # base*1.25*1.25 0.9375 > 0.8xxx (old value)
                - drug_id: 2
                  factors: [1.2, 1]
    - chromosome: 7
      genes:
        - name: "Pfcrt"
          multiplicative_effect_on_EC50_for_2_or_more_mutations:
            - drug_id: 3
              factor: 1.0
          average_daily_crs: 0.1290
          # 0.1290 is average of (0.1169,0.0081,0.2621 -  converted from fitness (2.19,2.46,1.83)) from Small-Sander PLOS 2019 paper (Mar 1 23 slides)
          aa_positions:
            - position: 76
              amino_acids: ["K", "T"]
              daily_crs: [0, 0.003875969]
              multiplicative_effect_on_EC50:
                - drug_id: 6
                  factors: [1, 1.6]
                - drug_id: 1
                  factors: [1.1, 1]
                - drug_id: 2
                  factors: [1, 1.2]
            - position: 93
              amino_acids: ["T", "S"]
              daily_crs: [0, 0.0002433748] #0.0000313953492 (this number is is supplement)  = (0.0081/0.1290)*0.0005
              multiplicative_effect_on_EC50:
                - drug_id: 3
                  factors: [1, 1.6648]
            - position: 97
              amino_acids: ["H", "Y"]
              daily_crs: [0, 0.003875969] #0.000500000001
              multiplicative_effect_on_EC50:
                - drug_id: 3
                  factors: [1, 1.6648]
            - position: 145
              amino_acids: ["F", "I"]
              daily_crs: [0, 0.0078751277] #0.0010158914733 (this number is in supplement)  = (0.2621/0.1290)*0.0005
              multiplicative_effect_on_EC50:
                - drug_id: 3
                  factors: [1, 2.2226]
            - position: 218
              amino_acids: ["I", "F"]
              daily_crs: [0, 0.0035124091] #0.0004531007739 (this number is in supplement) = (0.1169/0.1290)*0.0005
              multiplicative_effect_on_EC50:
                - drug_id: 3
                  factors: [1, 1.6648]
            - position: 343
              amino_acids: ["M", "L"]
              daily_crs: [0, 0.003875969] #0.000500000001
              multiplicative_effect_on_EC50:
                - drug_id: 3
                  factors: [1, 1.0]
            - position: 353
              amino_acids: ["G", "V"]
              daily_crs: [0, 0.003875969] #0.000500000001
              multiplicative_effect_on_EC50:
                - drug_id: 3
                  factors: [1, 1.0]
        - name: "Pfkaf"
          aa_positions:
            - position: 500
              amino_acids: ["x", "X"]
              daily_crs: [0, 0.0005]
              multiplicative_effect_on_EC50:
                - drug_id: 7
                  factors: [1, 1.6]
    - chromosome: 13
      genes:
        - name: "Pfkelch13"
          multiplicative_effect_on_EC50_for_2_or_more_mutations:
            - drug_id: 0
              factor: 1.1
          aa_positions:
            - position: 446
              amino_acids: ["F", "I"]
              daily_crs: [0, 0.0005]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [1, 1.6]
            - position: 458
              amino_acids: ["N", "Y"]
              daily_crs: [0, 0.0005]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [1, 1.6]
            - position: 469
              amino_acids: ["C", "Y"]
              daily_crs: [0, 0.0005]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [1, 1.6]
            - position: 476
              amino_acids: ["M", "I"]
              daily_crs: [0, 0.0005]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [1, 1.6]
            - position: 493
              amino_acids: ["Y", "H"]
              daily_crs: [0, 0.0005]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [1, 1.6]
            - position: 539
              amino_acids: ["R", "T"]
              daily_crs: [0, 0.0005]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [1, 1.6]
            - position: 543
              amino_acids: ["I", "T"]
              daily_crs: [0, 0.0005]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [1, 1.6]
            - position: 553
              amino_acids: ["P", "L"]
              daily_crs: [0, 0.0005]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [1, 1.6]
            - position: 561
              amino_acids: ["R", "H"]
              daily_crs: [0, 0.0005]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [1, 1.6]
            - position: 574
              amino_acids: ["P", "L"]
              daily_crs: [0, 0.0005]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [1, 1.6]
            - position: 580
              amino_acids: ["C", "Y"]
              daily_crs: [0, 0.0005]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [1, 1.6]
            - position: 622
              amino_acids: ["R", "I"]
              daily_crs: [0, 0.0005]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [1, 1.6]
            - position: 675
              amino_acids: ["A", "V"]
              daily_crs: [0, 0.0005]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [1, 1.6]
    - chromosome: 14
      genes:
        - name: "Pfplasmepsin"
          max_copies: 2
          cnv_daily_crs: [0, 0.0005]
          cnv_multiplicative_effect_on_EC50:
            - drug_id: 3
              #factors: [ 1, 2.4137931 ] #old without pfcrt
              factors: [1, 1.37]
          aa_positions: []

  override_ec50_patterns:
    - pattern: "||||NY1||K......,.||||||.............|."
      drug_id: 1
      ec50: 0.8
    - pattern: "||||YY1||K......,.||||||.............|."
      drug_id: 1
      ec50: 0.67
    - pattern: "||||NF1||K......,.||||||.............|."
      drug_id: 1
      ec50: 0.9
    - pattern: "||||YF1||K......,.||||||.............|."
      drug_id: 1
      ec50: 0.8
    - pattern: "||||NY2||K......,.||||||.............|."
      drug_id: 1
      ec50: 1.0
    - pattern: "||||YY2||K......,.||||||.............|."
      drug_id: 1
      ec50: 0.87
    - pattern: "||||NF2||K......,.||||||.............|."
      drug_id: 1
      ec50: 1.1
    - pattern: "||||YF2||K......,.||||||.............|."
      drug_id: 1
      ec50: 1.0
    - pattern: "||||NY1||T......,.||||||.............|."
      drug_id: 1
      ec50: 0.75
    - pattern: "||||YY1||T......,.||||||.............|."
      drug_id: 1
      ec50: 0.6
    - pattern: "||||NF1||T......,.||||||.............|."
      drug_id: 1
      ec50: 0.85
    - pattern: "||||YF1||T......,.||||||.............|."
      drug_id: 1
      ec50: 0.75
    - pattern: "||||NY2||T......,.||||||.............|."
      drug_id: 1
      ec50: 0.95
    - pattern: "||||YY2||T......,.||||||.............|."
      drug_id: 1
      ec50: 0.8
    - pattern: "||||NF2||T......,.||||||.............|."
      drug_id: 1
      ec50: 1.05
    - pattern: "||||YF2||T......,.||||||.............|."
      drug_id: 1
      ec50: 0.95
    - pattern: "||||NY.||K......,.||||||.............|."
      drug_id: 2
      ec50: 0.62
    - pattern: "||||YY.||K......,.||||||.............|."
      drug_id: 2
      ec50: 0.85
    - pattern: "||||NF.||K......,.||||||.............|."
      drug_id: 2
      ec50: 0.5
    - pattern: "||||YF.||K......,.||||||.............|."
      drug_id: 2
      ec50: 0.775
    - pattern: "||||NY.||T......,.||||||.............|."
      drug_id: 2
      ec50: 0.7
    - pattern: "||||YY.||T......,.||||||.............|."
      drug_id: 2
      ec50: 0.9
    - pattern: "||||NF.||T......,.||||||.............|."
      drug_id: 2
      ec50: 0.65
    - pattern: "||||YF.||T......,.||||||.............|."
      drug_id: 2
      ec50: 0.82

  initial_parasite_info:
    - location_id: -1 # -1 indicates all locations
      parasite_info:
        - aa_sequence: "||||YF1||TTHFIMG,x||||||FNCMYRIPRPCRA|1"
          prevalence: 0.05
        - aa_sequence: "||||YF1||TTHFIMG,x||||||FNCMYRIPRPCRA|1"
          prevalence: 0.05

# ---------------------------------------------------------------
# 11. Drug Parameters
# ---------------------------------------------------------------
drug_parameters:
  drug_db:
    0:
      name: "Artemisinin"
      half_life: 0.0
      maximum_parasite_killing_rate: 0.999
      n: 25
      age_specific_drug_concentration_sd: [0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4]
      k: 4
      base_EC50: 0.75
    1:
      name: "Lumefantrine"
      half_life: 4.5
      maximum_parasite_killing_rate: 0.99
      n: 20
      age_specific_drug_concentration_sd: [0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4]
      age_specific_drug_absorption: [0.7, 0.7, 0.85, 0.85, 0.85, 0.85, 0.85, 0.85, 0.85, 0.85, 1.0, 1.0, 1.0, 1.0, 1.0]
      k: 4
      base_EC50: 0.6
    2:
      name: "Amodiaquine"
      half_life: 9.0
      maximum_parasite_killing_rate: 0.95
      n: 19
      age_specific_drug_concentration_sd: [0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4]
      k: 4
      base_EC50: 0.5
    3:
      name: "Piperaquine"
      half_life: 28.0
      maximum_parasite_killing_rate: 0.9
      n: 15
      age_specific_drug_concentration_sd: [0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4]
      k: 4
      base_EC50: 0.58
    #MQ
    4:
      name: "Mefloquine"
      half_life: 21.0
      maximum_parasite_killing_rate: 0.9
      n: 15
      age_specific_drug_concentration_sd: [0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4]
      k: 4
      base_EC50: 0.45
      resistant_genes: ["Pfmdr1"]
    5:
      name: "SP"
      half_life: 6.5
      maximum_parasite_killing_rate: 0.9
      age_specific_drug_concentration_sd: [0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4]
      n: 15
      k: 4
      base_EC50: 1.08
      resistant_genes: []
    6:
      name: "CQ"
      half_life: 10
      maximum_parasite_killing_rate: 0.95
      n: 19
      age_specific_drug_concentration_sd: [0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4]
      k: 4
      base_EC50: 0.72
    7:
      name: "KAF156"
      half_life: 1.6
      maximum_parasite_killing_rate: 0.99
      n: 15
      age_specific_drug_concentration_sd: [0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4]
      k: 4
      base_EC50: 0.55
    8:
      name: "Generic"
      half_life: 7
      maximum_parasite_killing_rate: 0.8
      n: 15
      age_specific_drug_concentration_sd: [0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4]
      k: 4
      base_EC50: 0.68

# ---------------------------------------------------------------
# 12. Therapy Parameters
# ---------------------------------------------------------------
therapy_parameters:
  # Testing day for determining if treatment failed
  tf_testing_day: 28

  # Treatment failure rate used to determine whether a therapy is "useful"
  tf_rate: 0.1

  therapy_db:
    #mono as
    0:
      name: "Mono Artemisinin"
      drug_ids: [0]
      dosing_days: [3]
    #mono Lumefaltrine
    1:
      name: "Mono Lumefantrine"
      drug_ids: [1]
      dosing_days: [3]
    #mono AQ
    2:
      name: "Mono Amodiaquine"
      drug_ids: [2]
      dosing_days: [3]
    #mono PPQ
    3:
      name: "Mono Piperaquine"
      drug_ids: [3]
      dosing_days: [3]
    #mono MQ
    4:
      name: "Mono Mefloquine"
      drug_ids: [4]
      dosing_days: [3]
    #mono SP
    5:
      name: "Mono SP"
      drug_ids: [5]
      dosing_days: [3]
    #AL
    6:
      name: "AL"
      drug_ids: [0, 1]
      dosing_days: [3]
      #pr_completed_days: [0.0, 0.375, 0.375] #From TMS RWA
    #AS-AQ
    7:
      name: "AS-AQ"
      drug_ids: [0, 2]
      dosing_days: [3]
    # DHA-PPQ
    8:
      name: "DHA-PPQ"
      drug_ids: [0, 3]
      dosing_days: [3]
    #AS-MQ
    9:
      name: "AS-MQ"
      drug_ids: [0, 4]
      dosing_days: [3]
    #TACT DHA-PPQ-MQ
    10:
      name: "TACT DHA-PPQ-MQ"
      drug_ids: [0, 3, 4]
      dosing_days: [3]
    #TACT AL-AQ
    11:
      name: "TACT AL-AQ"
      drug_ids: [0, 1, 2]
      dosing_days: [3]
    #CQ
    12:
      name: "CQ"
      drug_ids: [6]
      dosing_days: [3]
    #Generic for Burn-in
    13:
      name: "Generic 80% Effective"
      drug_ids: [8]
      dosing_days: [3]
    #this is a MAC Therapy
    14:
      name: "MAC DHAPPQ"
      therapy_ids: [0, 0]
      regimen: [1, 7]

recurrence_therapy_id: 7

# ---------------------------------------------------------------
# 13. Treatment Strategy Parameters
# ---------------------------------------------------------------
strategy_parameters:
  strategy_db:
    0:
      name: SP-AQ-CQ-AL-MFTStrategy
      type: MFT
      therapy_ids: [5, 2, 12, 6]
      distribution: [0.3, 0.3, 0.3, 0.1]
    1:
      name: AL-SFTStrategy
      type: SFT
      therapy_ids: [6]
    2:
      name: ASAQ-SFTStrategy
      type: SFT
      therapy_ids: [7]
    3:
      name: CyclingStrategy
      type: Cycling
      therapy_ids: [8, 7, 6]
      cycling_time: 1825
    4:
      name: AdaptiveCyclingStrategy
      type: AdaptiveCycling
      therapy_ids: [8, 7, 6]
      trigger_value: 0.1
      delay_until_actual_trigger: 365
      turn_off_days: 365
    5:
      name: MFTStrategy
      type: MFT
      therapy_ids: [8, 7, 6]
      distribution: [0.333333, 0.333333, 0.333334]
    6:
      name: AL-ASAQ-DP-MFTRebalancingStrategy1
      type: MFTRebalancing
      therapy_ids: [8, 7, 6]
      distribution: [0.333333, 0.333333, 0.333334]
      delay_until_actual_trigger: 365
      update_duration_after_rebalancing: 365
    7:
      name: AL-ASAQ-DP-MFTRebalancingStrategy2
      type: MFTRebalancing
      therapy_ids: [8, 7, 6]
      distribution: [0.333333, 0.333333, 0.333334]
      delay_until_actual_trigger: 365
      update_duration_after_rebalancing: 730
    8:
      name: AL-ASAQ-DP-MFTRebalancingStrategy4
      type: MFTRebalancing
      therapy_ids: [8, 7, 6]
      distribution: [0.333333, 0.333333, 0.333334]
      delay_until_actual_trigger: 365
      update_duration_after_rebalancing: 1460
    9:
      name: DPM-SFTStrategy
      type: SFT
      therapy_ids: [10]
    10:
      name: AL-AQ-SFTStrategy
      type: SFT
      therapy_ids: [11]
    11:
      name: AL-BaseLineStrategy
      type: NestedMFT
      strategy_ids: [1, 0]
      start_distribution: [0.05, 0.95]
      peak_distribution: [0.8, 0.2]
      peak_after: 3650
    12:
      name: ASAQ-BaseLineStrategy
      type: MFTMultiLocation
      therapy_ids: [2, 0]
      start_distribution_by_location: [[0.05, 0.95]]
      peak_distribution_by_location: [[0.8, 0.2]]
      peak_after: 3650
    13:
      name: BaseLineStrategy
      type: NestedMFTMultiLocation
      strategy_ids: [0, 1]
      start_distribution_by_location: [[0.05, 0.95]]
      peak_distribution_by_location: [[0.8, 0.2]]
      peak_after: 3650
    14:
      name: DHAPPQ-SFTStrategy
      type: SFT
      therapy_ids: [8]
    15:
      name: Burnin-SFTStrategy
      type: SFT
      therapy_ids: [13]
    16:
      name: NovelDrugIntroductionStrategy
      type: NovelDrugIntroduction
      strategy_ids: [0, 3]
      start_distribution: [0.7, 0.3]
      peak_distribution: [0.7, 0.3]
      peak_after: 0
      newly_introduced_strategy_id: 4
      tf_threshold: 0.1
      replacement_fraction: 0.1
      replacement_duration: 0

  # Initial treatment strategy ID
  initial_strategy_id: 10

  # this is second line treatment for recurrence cases
  # -1 means use the same first line treatment for second line treatment
  recurrent_therapy_id: -1

  mass_drug_administration:
    # NOTE: This should be set with events to schedule rounds for MDA
    enable: false
    mda_therapy_id: 8
    age_bracket_prob_individual_present_at_mda: [10, 40]
    mean_prob_individual_present_at_mda: [0.85, 0.75, 0.85]
    sd_prob_individual_present_at_mda: [0.3, 0.3, 0.3]

# ---------------------------------------------------------------
# 14. Epidemiological Parameters
# ---------------------------------------------------------------
epidemiological_parameters:
  # number of days to keep track total number of parasites in population
  # in other words, the simulation stores 11 days of mosquitoes-biting-on-humans history
  # if an individual is infected today, the infection type and probability will be based
  # on the biting that took place 11 days ago
  number_of_tracking_days: 11
  # Days from end of liver-stage infection to appearance of symptoms
  days_to_clinical_under_five: 4
  days_to_clinical_over_five: 6

  # Days for parasites to develop mature gametocytes after exiting liver stage
  # Note: There are no explicit gametocytes in version 3.0.2 of the simulation
  days_mature_gametocyte_under_five: 4
  days_mature_gametocyte_over_five: 6

  # Probability that a patient completes a course of treatment
  p_compliance: 1

  # Guarantees that the minimum number of dosing days for a poorly complying patient is still 1
  min_dosing_days: 1

  # Relative biting rates for individuals
  relative_biting_info:
    max_relative_biting_value: 35
    min_relative_biting_value: 1.0
    number_of_biting_levels: 100
    biting_level_distribution:
      distribution: Gamma
      Exponential:
        scale: 0.17
      Gamma:
        mean: 5
        sd: 10

  # Gametocyte levels under artemisinin action and when full
  gametocyte_level_under_artemisinin_action: 1.0
  gametocyte_level_full: 1.0

  # Parameters determining the probability a mosquito becomes infected based on the host's parasitemia level
  relative_infectivity:
    sigma: 3.91
    ro: 0.00031
    blood_meal_volume: 3 # Average blood meal volume in microliters

  # Probability of relapse after no treatment or treatment failure
  p_relapse: 0.01

  # Number of days before a relapse can occur
  relapse_duration: 30

  # Relapse rate used to increase parasite density after treatment failure
  # Multiply by sqrt(20) per day
  relapse_rate: 4.4721

  # Minimum update frequency for a host's attributes (especially parasite density)
  # NOTE: consider remove this value as Person will be updated daily
  update_frequency: 7

  # Allows new co-infections to cause symptoms in infected but asymptomatic hosts
  allow_new_coinfection_to_cause_symptoms: true

  # Window size for observing treatment failure rates
  tf_window_size: 60

  # Fraction of mosquitoes experiencing interrupted feeding
  fraction_mosquitoes_interrupted_feeding: 0.0

  # Inflation factor for certain calculations
  inflation_factor: 0.01

  # special function to make the mean biting rate (across hosts) depend on age
  using_age_dependent_biting_level: false

  # special function which makes the probability of an infection (resulting
  # from an infectious mosquito bite) age-dependent
  using_variable_probability_infectious_bites_cause_infection: false

# ---------------------------------------------------------------
# 15. Mosquito Parameters (default is location based)
# ---------------------------------------------------------------
#TODO: Check this implementation in Mosquito class
mosquito_parameters:
  mosquito_config:
    mode: "location_based" # or "grid_based"
    grid_based:
      interrupted_feeding_rate_raster: "../sample_inputs/dev_mosquito_ifr.asc"
      prmc_size_raster: "../sample_inputs/dev_mosquito_size.asc"
    location_based:
      interrupted_feeding_rate: [0.19]
      prmc_size: [100]

  # Within-host induced free recombination
  within_host_induced_free_recombination: true

  # Record recombination events (only for Validation Reporter)
  # Note: this will generate a lot of data
  record_recombination_events: true

# ---------------------------------------------------------------
# 16. Population Events (all events are optional)
# ---------------------------------------------------------------
population_events:
  - name: turn_on_mutation
    info:
      - date: 2000/1/1

  - name: change_mutation_probability_per_locus
    info:
      - date: 2000/1/1
        mutation_probability_per_locus: 0.001

# ---------------------------------------------------------------
# 17. Optional settings
# ---------------------------------------------------------------
rapt_settings:
  enabled: false
  period: 12
  therapy_id: 1
  compliance: 0.7
  age_start: 18
  start_date: 2002/08/18
